• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氨基-4-(重氮乙酰基)-1-β-D-呋喃核糖基咪唑,一种新型抗白血病药物。

5-Amino-4-(diazoacetyl)-1-beta-D-ribofuranosylimidazole, a new antileukemic agent.

作者信息

Thomas H J, Avery L N, Brockman R W, Montgomery J A

出版信息

J Med Chem. 1987 Feb;30(2):431-4. doi: 10.1021/jm00385a030.

DOI:10.1021/jm00385a030
PMID:3027342
Abstract

5-Amino-4-(diazoacetyl)-1-beta-D-ribofuranosylimidazole (15), 5-amino-4-(chloroacetyl)-1-beta-D-ribofuranosylimidazole (16), and a number of related imidazole ribonucleosides have been synthesized. Compounds 15 and 16 are cytotoxic to both H.Ep.-2 and L1210 leukemia cells in culture. The (diazoacetyl)imidazole 15 is also active against the P388 leukemia in mice.

摘要

已合成了5-氨基-4-(重氮乙酰基)-1-β-D-呋喃核糖基咪唑(15)、5-氨基-4-(氯乙酰基)-1-β-D-呋喃核糖基咪唑(16)以及许多相关的咪唑核糖核苷。化合物15和16在培养中对H.Ep.-2和L1210白血病细胞均具有细胞毒性。(重氮乙酰基)咪唑15对小鼠的P388白血病也有活性。

相似文献

1
5-Amino-4-(diazoacetyl)-1-beta-D-ribofuranosylimidazole, a new antileukemic agent.5-氨基-4-(重氮乙酰基)-1-β-D-呋喃核糖基咪唑,一种新型抗白血病药物。
J Med Chem. 1987 Feb;30(2):431-4. doi: 10.1021/jm00385a030.
2
Synthesis and biological activity of 5-thiobredinin and certain related 5-substituted imidazole-4-carboxamide ribonucleosides.5-硫代布雷迪宁及某些相关的5-取代咪唑-4-甲酰胺核糖核苷的合成与生物活性
J Med Chem. 1985 Sep;28(9):1198-203. doi: 10.1021/jm00147a013.
3
Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.核苷与核苷酸。96. 5-乙炔基-1-β-D-呋喃核糖基咪唑-4-甲酰胺(EICAR)及其衍生物的合成与抗肿瘤活性
J Med Chem. 1991 Feb;34(2):778-86. doi: 10.1021/jm00106a045.
4
(+/-)-3-(4-Amino-1H-pyrrolo[2,3-d]pyrimidin-1-yl)-5-(hydroxymethyl)- (1 alpha,2 alpha,3 beta,5 beta)-1,2-cyclopentanediol, the carbocyclic analogue of tubercidin.(±)-3-(4-氨基-1H-吡咯并[2,3-d]嘧啶-1-基)-5-(羟甲基)-(1α,2α,3β,5β)-1,2-环戊二醇,结核菌素的碳环类似物。
J Med Chem. 1984 Apr;27(4):534-6. doi: 10.1021/jm00370a018.
5
The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides.5-炔基-1-β-D-呋喃核糖基咪唑-4-甲酰胺的设计、合成及抗白血病活性
Chem Pharm Bull (Tokyo). 1988 Jul;36(7):2730-3. doi: 10.1248/cpb.36.2730.
6
Synthesis, antiproliferative, and antiviral activity of 4-amino-1-(beta-D-ribofuranosyl)pyrrolo[2,3-d]pyridazin-7(6H)-one and related derivatives.4-氨基-1-(β-D-呋喃核糖基)吡咯并[2,3-d]哒嗪-7(6H)-酮及其相关衍生物的合成、抗增殖和抗病毒活性
J Med Chem. 1993 Nov 26;36(24):3834-42. doi: 10.1021/jm00076a011.
7
Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles.某些1-β-D-呋喃核糖基-4,5-二取代咪唑的合成及其抗病毒和抗菌活性
J Med Chem. 1976 Aug;19(8):1020-6. doi: 10.1021/jm00230a009.
8
Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.与抗肿瘤剂2-β-D-呋喃核糖基噻唑-4-甲酰胺相关的核苷和核苷酸的合成及生物活性
J Med Chem. 1984 Mar;27(3):266-9. doi: 10.1021/jm00369a006.
9
Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.基于机制的肌苷5-单磷酸脱氢酶抑制剂设计:5-乙炔基-1-β-D-呋喃核糖基咪唑-4-甲酰胺(EICAR)及其衍生物的合成与生物活性
Curr Med Chem. 1999 Jul;6(7):615-28.
10
5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷(AICA-核苷)作为急性淋巴细胞白血病患者治疗的靶向药物:我们成功了吗?有哪些陷阱?
J Pediatr Hematol Oncol. 2007 Dec;29(12):805-7. doi: 10.1097/MPH.0b013e31815bbb83.

引用本文的文献

1
Nonenzymatic synthesis of 5-aminoimidazole ribonucleoside and recognition of its facile rearrangement.5-氨基咪唑核糖核苷的非酶促合成及其易重排的识别
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7174-6. doi: 10.1073/pnas.85.19.7174.